EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy

Blake R Baer iD, Meghan V Matheny iD, Raidizon H Mercedes, Jay D Raman

Current Oncology · 2025

DOI: 10.3390/curroncol32030125 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Current Oncology, 2025. Verfasst von Blake R Baer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Penn State Health, Milton S. Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA. Hauptthemen laut MEDLINE: Nephroureterectomy, Ablation Techniques, Urologic Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Upper tract urothelial carcinoma (UTUC) is typically managed through radical nephroureterectomy (RNU) or local ablation (LA). Compared to RNU, LA offers nephron-sparing benefit for select patients but may present increased recurrence risk. This study primarily compares long-term differences between LA and RNU in chronic kidney disease (CKD) progression, estimated glomerular filtration rate (eGFR) decline, all-cause mortality, and need for dialysis. (2)

Methods

A retrospective cohort study was conducted using the TriNetX database, examining patients with UTUC treated with RNU (n = 2007) or LA (n = 4172). Propensity score matching balanced both cohorts (n = 1965 per group). Risk ratios and hazard ratios with 95% confidence intervals were calculated over 10 years. (3)

Results

At 10 years, LA preserved higher mean eGFR (53.49 vs. 46.72; p < 0.001) and lower mean creatinine (1.56 vs. 1.66; p = 0.017). However, LA held a higher incidence of end-stage renal disease (ESRD) (3.6% vs. 2.2%, p = 0.008) and all-cause mortality (26.7% vs. 23.5%, p = 0.016). There was no significant difference in rates of dialysis (p = 0.79). (4)

Conclusions

RNU did not carry an increased risk of ESRD, advanced stages of CKD, need for renal dialysis, or overall mortality compared with LA. LA may delay but not totally prevent renal dysfunction when compared to RNU, and exhibits a more gradual timeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephroureterectomyAblation TechniquesUrologic NeoplasmsKidney NeoplasmsCarcinoma, Transitional CellHumansMaleFemaleAgedRetrospective StudiesMiddle AgedTreatment OutcomeGlomerular Filtration Rate

Stichwörter der Autor:innen

CKDGFRUTUCablationdialysishematurianephroureterectomyurothelial

Autor:innen und Institutionen

  • Department of Urology, Penn State Health, Milton S. Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA.
  • College of Medicine, Penn State College of Medicine, 500 University Dr., Hershey, PA 17033, USA.

ORCID-Profile: Blake R Baer, Meghan V Matheny

Förderung

  • NCATS NIH HHS

Zitieren

APA

Baer, B. R., Matheny, M. V., Mercedes, R. H., & Raman, J. D. (2025). Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Current Oncology. https://doi.org/10.3390/curroncol32030125

Vancouver

Baer BR, Matheny MV, Mercedes RH, Raman JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Current Oncology. 2025. doi:10.3390/curroncol32030125

BibTeX
@article{Baer2025,
  author = {Baer, Blake R and Matheny, Meghan V and Mercedes, Raidizon H and Raman, Jay D},
  title = {Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32030125}
}
Kostenlos starten →